copper peptide ghk-cu clinical trial skin anti-aging randomized Buy GHK-Cu Copper Peptide |
Description
Directed cell growth in multi-zonal scaffolds for cartilage tissue engineering
Patient Questionnaires Questionnaires were administered at the screening visit and then weekly during the dosing and follow-up period of 3 months (total 16 wks)
10 mg vial Concentration: 10 mg 3 mL = 3.333 mg/mL (equivalently 3,333 mcg/mL) Dose in mg: 600 mcg = 0.6 mg Draw volume: 0.6 mg 3.333 mg/mL = 0.18 mL Syringe units: 0.18 mL 100 = 18 units on a U-100 syringe So on the 10 mg vial, one documented dose is a draw to the 18-unit mark
You want to fix the damage and address the underlying cause(s) of that damage
